By Authors

Publications - sorted by Authors

• Krajnc N, Schmidbauer V, Leinkauf J, Haider L, Bsteh G, Kasprian G, Leutmezer F, Kornek B, Rommer P, Berger T, Lassmann H, Dal-Bianco A, Hametner S (2023) Paramagnetic rim lesions lead to pronounced diffuse periplaque white matter damage in multiple sclerosis Mult Scler, 29(11-12): 1406-1417
• Krajnc N, Dal-Bianco A, Leutmezer F, Kasprian G, Pemp B, Kornek B, Berger T, Rommer P, Hametner S, Lassmann H, Bsteh G (2023) Association of paramagnetic rim lesions and retinal layer thickness in patients with multiple sclerosis Mult Scler, 29(3): 374-384

• Krajnc N, Bsteh G, Kasprian G, Zrzavy T, Kornek B, Berger T, Leutmezer F, Rommer P, Lassmann H, Hametner S, Dal-Bianco A (2022) Peripheral Hemolysis in Relation to Iron Rim Presence and Brain Volume in Multiple Sclerosis Front Neurol, 13: 928582

• Altmann P, Leithner K, Leutmezer F, Monschein T, Ponleitner M, Stattmann M, Rommer P, Zrzavy T, Zulehner G, Berek K, Berger T, Bsteh G (2021) Sexuality and Multiple Sclerosis: Patient and Doctor Perspectives JSM, 18 (4): 743-749
• Altmann P, Leutmezer F, Leithner K, Monschein T, Ponleitner M, Stattmann M, Rommer P, Zrzavy T, Zulehner G, Berek K, Berger T, Bsteh G (2021) Predisposing Factors for Sexual Dysfunction in Multiple Sclerosis Front Neurol, 12: 618370
• Monschein T, Schestak C, Schillerwein-Kral C, Leutmezer F, Berger T, Bsteh G, Seidel S (2021) Restless Legs Syndrome in Multiple Sclerosis: Risk factors and effect on sleep quality – a case-control study Mult Scler Relat Disord., 51: 102916
• Dal-Bianco A, Schranzer R, Grabner G, Lanzinger M, Kolbrink S, Pusswald G, Altmann P, Ponleitner M, Weber M, Kornek B, Zebenholzer K, Schmied C, Berger T, Lassmann H, Trattnig S, Hametner S, Leutmezer F, Rommer P (2021) Iron Rims in Patients With Multiple Sclerosis as Neurodegenerative Marker? A 7-Tesla Magnetic Resonance Study Front Neurol, 12: 632749
• Zrzavy T, Wielandner A, Haider L, Bartsch S, Leutmezer F, Berger T, Nenning KH, Rauscher A, Rommer P, Kasprian G (2021) FLAIR2 post-processing: improving MS lesion detection in standard MS imaging protocols J Neurol,
• Bsteh G, Hegen H, Altmann P, Auer M, Berek K, Di Pauli F, Leutmezer F, Rommer P, Wurth S, Zinganell A, Zrzavy T, Deisenhammer F, Berger T (2021) Retinal layer thinning predicts treatment failure in relapsing multiple sclerosis Eur J Neurol, 28 (6): 2037-2045
• Zrzavy T, Daniels E, Stuka N, Weber D, Winkelmann A, Rauschka H, Hecker M, Aboulenein-Djamshidian F, Meister S, Leutmezer F, Berger T, Bsteh G, Zettl UK, Rommer P (2021) Rituximab versus mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis Therapeutic Advances in Chronic Disease, 12: 204062232110243
• Dal-Bianco A, Grabner G, Kronnerwetter C, Weber M, Kornek B, Kasprian G, Berger T, Leutmezer F, Rommer P, Trattnig S, Lassmann H, Hametner S (2021) Long-term evolution of multiple sclerosis iron rim lesions in 7 T MRI Brain, 144(3): 833-847

• Monschein T, Salhofer-Polanyi S, Altmann P, Zrzavy T, Dal-Bianco A, Bsteh G, Rommer P, Berger T, Leutmezer F (2020) Should I stop or should I go on? Disease modifying therapy after the first clinical episode of multiple sclerosis J Neurol, 268 (4): 1247-1253
• Altmann P, De Simoni D, Kaider A, Ludwig B, Rath J, Leutmezer F, Zimprich F, Hoeftberger R, Lunn M, Heslegrave A, Berger T, Zetterberg H, Rommer P (2020) Increased serum neurofilament light chain concentration indicates poor outcome in Guillain-Barré syndrome J Neuroinflammation, 17 (1)
• Tsymala I, Nigritinou M, Zeka B, Schulz R, Niederschick F, Matković M, Bauer I, Szalay M, Schanda K, Lerch M, Misu T, Fujihara K, Bennett J, Dahle C, Pache F, Rommer P, Leutmezer F, Illes Z, Leite M, Palace J, Scholze P, Reindl M, Lassmann H, Bradl M (2020) Induction of aquaporin 4-reactive antibodies in Lewis rats immunized with aquaporin 4 mimotopes Acta Neuropathologica Communications, 15; 8 (1)
  | Supplement |

• Heckova E, Strasser B, Hangel G, Považan M, Dal-Bianco A, Rommer P, Bednarik P, Gruber S, Leutmezer F, Lassmann H, Trattnig S, Bogner W (2019) 7 T Magnetic Resonance Spectroscopic Imaging in Multiple Sclerosis Invest Radiol, 54(4): 247-254

• Milos R, Szimacsek M, Leutmezer F, Rostasy K, Blaschek A, Karenfort M, Schimmel M, Pritsch M, Storm van's Gravesande K, Weber M, Schmoeger M, Seidl R, Prayer D, Kornek B (2018) Clinical and magnetic resonance imaging features of children, adolescents, and adults with a clinically isolated syndrome EJPN, 22 (6): 1087-1094
• Reinthaler E, Graf E, Zrzavy T, Wieland T, Hotzy C, Kopecky C, Pferschy S, Schmied C, Leutmezer F, Keilani M, Lill C, Hoffjan S, Epplen J, Zettl U, Hecker M, Deutschländer A, Meuth S, Ahram M, Mustafa B, El-Khateeb M, Vilariño-Güell C, Sadovnick A, Zimprich F, Tomkinson B, Strom T, Kristoferitsch W, Lassmann H, Zimprich A (2018) TPP2 mutation associated with sterile brain inflammation mimicking MS Neurol Genet, 4 (6): e285
• Zrzavy T, Kovacs-Nagy R, Reinthaler E, Deutschländer A, Schmied C, Kornek B, Leutmezer F, Zimprich A (2018) A rare P2RX7 variant in a Hungarian family with Multiple Sclerosis Mult Scler Relat Disord.,

• Dal-Bianco A, Grabner G, Kronnerwetter C, Weber M, Höftberger R, Berger T, Auff E, Leutmezer F, Trattnig S, Lassmann H, Bagnato F, Hametner S (2017) Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging Acta Neuropathol, 133 (1): 25-42
• Salhofer-Polanyi S, Cetin H, Leutmezer F, Baumgartner A, Blechinger S, Dal-Bianco A, Altmann P, Bajer-Kornek B, Rommer P, Guger M, Leitner-Bohn D, Reichardt B, Alasti F, Temsch W, Stamm T (2017) Epidemiology of Multiple Sclerosis in Austria Neuroepidemiol, 49 (1-2): 40-44
• Ehler J, Blechinger S, Rommer P, Koball S, Mitzner S, Hartung H, Leutmezer F, Sauer M, Zettl U (2017) Treatment of the First Acute Relapse Following Therapeutic Plasma Exchange in Formerly Glucocorticosteroid-Unresponsive Multiple Sclerosis Patients—A Multicenter Study to Evaluate Glucocorticosteroid Responsiveness Int J Mol Sci, 18 (8): 1749

• Reinthaler EM, Graf E, Zrzavy T, Wieland T, Hotzy C, Kopecky CM, Schmied C, Leutmezer FH, Keilani MY, Lill CM, Hoffjan S, Epplen JT, Zettl UK, Hecker M, Deutschlaender A, Ahram M, Mustafa B, El-Khateeb M, Vilarino-Guell C, Sadovnick DA, Zimprich F, Tomkinson B, Strom TM, Kristoferitsch W, Lassmann H, Zimprich A (2016) Mutations in the gene tripeptidyl peptidase II (TPP2) and multiple sclerosis Mult Scler, 22: 849
• Tuller F, Holzer H, Schanda K, Aboulenein-Djamshidian F, Höftberger R, Khalil M, Seifert-Held T, Leutmezer F, Berger T, Reindl M (2016) Characterization of the binding pattern of human aquaporin-4 autoantibodies in patients with neuromyelitis optica spectrum disorders J Neuroinflammation, 13 (1)
• Zeka B, Hastermann M, Kaufmann N, Schanda K, Pende M, Misu T, Rommer P, Fujihara K, Nakashima I, Dahle C, Leutmezer F, Reindl M, Lassmann H, Bradl M (2016) Aquaporin 4-specific T cells and NMO-IgG cause primary retinal damage in experimental NMO/SD Acta Neuropathologica Communications, 4 (1): 82

• Dal-Bianco A, Hametner S, Grabner G, Schernthaner M, Kronnerwetter C, Reitner A, Vass C, Kircher K, Auff E, Leutmezer F, Vass K, Trattnig S (2015) Veins in plaques of multiple sclerosis patients – a longitudinal magnetic resonance imaging study at 7 Tesla – Eur Radiol, 25 (10): 2913-2920
• Zeka B, Hastermann M, Hochmeister S, Kögl N, Kaufmann N, Schanda K, Mader S, Misu T, Rommer P, Fujihara K, Illes Z, Leutmezer F, Sato D, Nakashima I, Reindl M, Lassmann H, Bradl M (2015) Highly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNS Acta Neuropathol, 130 (6): 783-798
• Guger M, Enzinger C, Leutmezer F, Kraus J, Berger T (2015) Update - real life use of natalizumab and fingolimod in Austria: benefit-risk data from the Austrian multiple sclerosis treatment registry Mult Scler, 21: 281-281
• Walleczek NK, Rauschka H, Bsteh G, Birkl CB, Khalil M, Fuchs S, Enzinger C, Fazekas F, Eggers C, Leutmezer F, Salhofer-Polanyi S, Baumgartner A, Blechinger S, Koppi S, Sellner J, Kraus J, Assar H, Gugger M, Ehling R, Moser H, Raber B, Liendl H, Parigger S, Mayr M, Hiller MS, Meister B, Morgenstern G, Spiess HK, Kempf I, Cisar A, Bachler H, Lehninger R, Berger T, Kristoferitsch W, Aboulenein-Djamshidian F (2015) Month-of-birth-effect in multiple sclerosis in Austria Mult Scler, 21: 102-103
• Dal-Bianco A, Hametner S, Grabner G, Schernthaner M, Kronnerwetter C, Reitner A, Vass C, Kircher K, Auff E, Leutmezer F, Vass K, Trattnig S (2015) Veins in plaques of multiple sclerosis patients – a longitudinal magnetic resonance imaging study at 7 Tesla – Eur Radiol, 25 (10): 2913-2920

• Finsterer J, Leutmezer F (2014) Celiac disease with cerebral and peripheral nerve involvement mimicking multiple sclerosis J Med Life, 7(3): 440-4
• Salhofer-Polanyi S, Baumgartner A, Kraus J, Maida E, Schmied M, Leutmezer F, (2014) What to expect after natalizumab cessation in a real-life setting Acta Neurol Scand, 130 (2): 97-102
• Ringelstein M, Aktas O, Harmel J, Prayer D, Jarius S, Wildemann B, Hartung H, Salhofer-Polanyi S, Leutmezer F, Rommer P (2014) Biopsie bei tumorverdächtiger spinaler Raumforderung: Fallstrick Neuromyelitis optica Nervenarzt, 85 (10): 1298-1303
• Rommer P, Greilberger J, Salhofer-Polanyi S, Auff E, Leutmezer F, Herwig R (2014) Elevated Levels of Carbonyl Proteins in Cerebrospinal Fluid of Patients with Neurodegenerative Diseases Tohoku J. Exp. Med., 234 (4): 313-317

• Salhofer-Polanyi S, Leutmezer F (2014) Contemporary treatment options for relapsing-remitting multiple sclerosis Drugs Today, 50 (5): 365

• Ilhan-Mutlu A, Wagner L, Widhalm G, Wöhrer A, Bartsch S, Czech T, Heinzl H, Leutmezer F, Prayer D, Marosi C, Base W, Preusser M (2013) Exploratory investigation of eight circulating plasma markers in brain tumor patients Neurosurg Rev, 36 (1): 45-56
• Salhofer-Polanyi S, Windt J, Sumper H, Grill H, Essmeister M, Diermayr G, Zebenholzer K, Leutmezer F, Zulehner G, Vass K, Asenbaum-Nan S (2013) Benefits of inpatient multidisciplinary rehabilitation in multiple sclerosis NeuroRehabilitation, 33(2): 285-292
• Aboul-Enein F, Seifert-Held T, Mader S, Kuenz B, Lutterotti A, Rauschka H, Rommer P, Leutmezer F, Vass K, Flamm-Horak A, Stepansky R, Lang W, Fertl E, Schlager T, Heller T, Eggers C, Safoschnik G, Fuchs S, Kraus J, Assar H, Guggenberger S, Reisz M, Schnabl P, Komposch M, Simschitz P, Skrobal A, Moser A, Jeschow M, Stadlbauer D, Freimüller M, Guger M, Schmidegg S, Franta C, Weiser V, Koppi S, Niederkorn-Duft M, Raber B, Schmeissner I, Jecel J, Tinchon A, Storch M, Reindl M, Berger T, Kristoferitsch W (2013) Neuromyelitis Optica in Austria in 2011: To Bridge the Gap between Neuroepidemiological Research and Practice in a Study Population of 8.4 Million People PLoS One, 8 (11): e79649

• Schmied M, Zehetmayer S, Reindl M, Ehling R, Bajer-Kornek B, Leutmezer F, Zebenholzer K, Hotzy C, Lichtner P, Meitinger T, Wichmann H, Illig T, Gieger C, Huber K, Khalil M, Fuchs S, Schmidt H, Auff E, Kristoferitsch W, Fazekas F, Berger T, Vass K, Zimprich A (2012) Replication study of multiple sclerosis (MS) susceptibility alleles and correlation of DNA-variants with disease features in a cohort of Austrian MS patients Neurogenetics, 13 (2): 181-187

• Stogmann E, El Tawil S, Wagenstaller J, Gaber A, Edris S, Abdelhady A, Assem-Hilger E, Leutmezer F, Bonelli S, Baumgartner C, Zimprich F, Strom T, Zimprich A (2008) A novel mutation in the MFSD8 gene in late infantile neuronal ceroid lipofuscinosis Neurogenetics, 10 (1): 73-77
• Stogmann E, El Tawil S, Wagenstaller J, Gaber A, Edris S, Abdelhady A, Assem-Hilger E, Leutmezer F, Bonelli S, Baumgartner C, Zimprich F, Strom T, Zimprich A (2008) A novel mutation in the MFSD8 gene in late infantile neuronal ceroid lipofuscinosis Neurogenetics, 10 (1): 73-77
• Stogmann E, El Tawil S, Wagenstaller J, Gaber A, Edris S, Abdelhady A, Assem-Hilger E, Leutmezer F, Bonelli S, Baumgartner C, Zimprich F, Strom T, Zimprich A (2008) A novel mutation in the MFSD8 gene in late infantile neuronal ceroid lipofuscinosis Neurogenetics, 10 (1): 73-77

• Stogmann E, Lichtner P, Baumgartner C, Schmied M, Hotzy C, Asmus F, Leutmezer F, Bonelli S, Assem-Hilger E, Vass K, Hatala K, Strom TM, Meitinger T, Zimprich F, Zimprich A (2006) Mutations in the CLCN2 gene are a rare cause of idiopathic generalized epilepsy syndromes Neurogenetics,
• Stogmann E, Lichtner P, Baumgartner C, Bonelli S, Assem-Hilger E, Leutmezer F, Schmied M, Hotzy C, Strom TM, Meitinger T, Zimprich F, Zimprich A (2006) Idiopathic generalized epilepsy phenotypes associated with different EFHC1 mutations Neurology,

• Gallmetzer P, Leutmezer F, Serles W, Assem-Hilger E, Spatt J, Baumgartner C (2004) Postictal paresis in focal epilepsies--incidence, duration, and causes: a video-EEG monitoring study. Neurology, 62(12): 2160-4